CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-22 | GRAMMER ELIZABETH A | Sale | −537 | $0.99 | $533 | 275,958 |
| 2021-11-15 | Jacobs Jeffrey W Chief Scientific Officer | Sale | −5,000 | $1.13 | $6K | 125,237 |
| 2021-11-12 | GRAMMER ELIZABETH A | Sale | −77,432 | $1.13 | $87K | 276,495 |
| 2021-11-08 | Jacobs Jeffrey W Chief Scientific Officer | Sale | −2,166 | $1.18 | $3K | 130,237 |
| 2021-10-08 | RAAB MICHAEL President & CEO | Grant or award | +300,000 | 634,410 | ||
| 2021-10-08 | Rosenbaum David P. Chief Development Officer | Grant or award | +150,000 | 311,804 | ||
| 2021-10-08 | Rosenbaum David P. Chief Development Officer | Grant or award | +60,000 | 90,811 | ||
| 2021-10-08 | Rodriguez Susan Chief Commercial Officer | Grant or award | +150,000 | 197,673 | ||
| 2021-10-08 | Blanks Robert | Grant or award | +250,000 | 361,511 | ||
| 2021-10-08 | Renz Justin A Chief Financial Officer | Grant or award | +250,000 | 294,330 | ||
| 2021-10-08 | GRAMMER ELIZABETH A | Grant or award | −250,000 | 353,927 | ||
| 2021-08-20 | Rosenbaum David P. Chief Development Officer | Sale | −631 | $1.32 | $833 | 158,804 |
| 2021-08-20 | Rosenbaum David P. Chief Development Officer | Sale | −176 | $1.32 | $232 | 26,574 |
| 2021-08-20 | Rodriguez Susan Chief Commercial Officer | Sale | −630 | $1.32 | $832 | 44,673 |
| 2021-08-20 | Renz Justin A Chief Financial Officer | Sale | −631 | $1.32 | $833 | 40,047 |
| 2021-08-20 | RAAB MICHAEL President & CEO | Sale | −2,573 | $1.32 | $3K | 329,730 |
| 2021-08-20 | Jacobs Jeffrey W Chief Scientific Officer | Sale | −741 | $1.32 | $978 | 127,697 |
| 2021-08-20 | GRAMMER ELIZABETH A | Sale | −526 | $1.32 | $694 | 102,386 |
| 2021-08-20 | Blanks Robert | Sale | −631 | $1.32 | $833 | 106,323 |
| 2021-08-03 | RAAB MICHAEL President & CEO | Exercise or conversion | +267,892 | $0.54 | $145K | 482,646 |
Page 29 of 38 · 756 trades